KP
Insider selling
Kush Parmar sold $1.1M of TRDA stock
Kush Parmar, Dir of Entrada Therapeutics, Inc. (TRDA), sold 155,255 shares of TRDA stock worth $1.1M, per an SEC Form 4 filed Aug 10, 2026.
It was an open-market sale.
The trade happened on Aug 6, 2026, 4 days before it was made public.
TRDA has moved -34.0% since the trade date, from $6.87 to $4.54 (Oct 30, 2026 close).
- Traded
- Aug 6, 2026
- Disclosed
- Aug 10, 2026
- Filing delay
- 4 days
- Price since
- -34.0%
- Role
- Dir
- Source
- SEC Form 4
More TRDA insider and Congress trades
- SellTRDA · MPM Bioventures 2018, L.P.$1.9MSep 9, 2026
- SellTRDA · MPM BioVentures 2014, L.P.$1.9MSep 9, 2026
- SellTRDA · MPM Bioventures 2018, L.P.$617KSep 3, 2026
- SellTRDA · MPM BioVentures 2014, L.P.$617KSep 3, 2026
- SellTRDA · MPM Bioventures 2018, L.P.$616KAug 31, 2026
- SellTRDA · MPM BioVentures 2014, L.P.$616KAug 31, 2026
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.